Literature DB >> 22399294

MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.

Rui-Qing Peng1, Hai-Ying Wan, Hai-Fang Li, Min Liu, Xin Li, Hua Tang.   

Abstract

MicroRNAs are a class of small noncoding RNAs that function as key regulators of gene expression at the post-transcriptional level. In this study, we demonstrate that miR-214 is frequently down-regulated in cervical cancer, and its expression reduces the proliferation, migration, and invasiveness of cervical cancer cells, whereas inhibiting its expression results in enhanced proliferation, migration, and invasion. miR-214 binds to the 3'-UTR of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7), thereby repressing GALNT7 expression. Furthermore, we are the first to show, using quantitative real-time PCR, that GALNT7 is frequently up-regulated in cervical cancer. The knockdown of GALNT7 markedly inhibits cervical cancer cell proliferation, migration, and invasion, whereas ectopic expression of GALNT7 significantly enhances these properties, indicating that GALNT7 might function as an oncogene in cervical cancer. The restoration of GALNT7 expression can counteract the effect of miR-214 on cell proliferation, migration, and invasiveness of cervical cancer cells. Together, these results indicate that miR-214 is a new regulator of GALNT7, and both miR-214 and GALNT7 play important roles in the pathogenesis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399294      PMCID: PMC3340176          DOI: 10.1074/jbc.M111.337642

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Identification of novel genes coding for small expressed RNAs.

Authors:  M Lagos-Quintana; R Rauhut; W Lendeckel; T Tuschl
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

2.  MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.

Authors:  Kin Wai Lai; King Xin Koh; Marie Loh; Kotaro Tada; Manish Mani Subramaniam; Xn Yii Lim; Aparna Vaithilingam; Manuel Salto-Tellez; Barry Iacopetta; Yoshiaki Ito; Richie Soong
Journal:  Eur J Cancer       Date:  2010-02-20       Impact factor: 9.162

3.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 4.  Pathways of O-glycan biosynthesis in cancer cells.

Authors:  I Brockhausen
Journal:  Biochim Biophys Acta       Date:  1999-12-06

5.  Aberrant microRNA expression in human cervical carcinomas.

Authors:  Qunxian Rao; Qingli Shen; Hui Zhou; Yongpai Peng; Jing Li; Zhongqiu Lin
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

6.  KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.

Authors:  Hanfeng Guan; Linka Xie; Frank Leithäuser; Lucia Flossbach; Peter Möller; Thomas Wirth; Alexey Ushmorov
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

7.  MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.

Authors:  Jian Yao; Linhui Liang; Shenglin Huang; Jie Ding; Ning Tan; Yingjun Zhao; Mingxia Yan; Chao Ge; Zhenfeng Zhang; Taoyang Chen; Dafang Wan; Ming Yao; Jinjun Li; Jianren Gu; Xianghuo He
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

8.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

9.  MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.

Authors:  Shireen Kahai; Shao-Chen Lee; Daniel Y Lee; Jennifer Yang; Minhui Li; Chia-Hui Wang; Zide Jiang; Yaou Zhang; Chun Peng; Burton B Yang
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

10.  MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells.

Authors:  Zuozhen Yang; Shuang Chen; Xuejing Luan; Yixuan Li; Min Liu; Xin Li; Tao Liu; Hua Tang
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

View more
  79 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

2.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

3.  Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.

Authors:  Yidong Liu; Haiou Liu; Liu Yang; Qian Wu; Weisi Liu; Qiang Fu; Weijuan Zhang; Haijian Zhang; Jiejie Xu; Jianxin Gu
Journal:  J Biol Chem       Date:  2017-01-06       Impact factor: 5.157

4.  Development of isoform-specific sensors of polypeptide GalNAc-transferase activity.

Authors:  Lina Song; 丽娜 宋; Collin Bachert; Katrine T Schjoldager; Henrik Clausen; Adam D Linstedt
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

Review 5.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

6.  Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx.

Authors:  Leonhard Möckl; Kayvon Pedram; Anish R Roy; Venkatesh Krishnan; Anna-Karin Gustavsson; Oliver Dorigo; Carolyn R Bertozzi; W E Moerner
Journal:  Dev Cell       Date:  2019-05-16       Impact factor: 12.270

7.  MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.

Authors:  Jian-Mei Wang; Bao-Hui Ju; Cai-Jun Pan; Yan Gu; Meng-Qi Li; Li Sun; Yan-Ying Xu; Li-Rong Yin
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 8.  Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway.

Authors:  Dengliang Huang; Yiting Wang; Jiabin Tang; Shiwen Luo
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

9.  Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development.

Authors:  Lanwei Guo; Juan Wen; Jing Han; Jie Jiang; Shuanghua Xie; Xiaoshuang Feng; Baojun Wei; Juncheng Dai; Kai Zhang; Jun Qi; Hongxia Ma; Jufang Shi; Jiansong Ren; Yue Zhang; Min Dai; Zhibin Hu; Ni Li
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

10.  miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.

Authors:  Qijue Lu; Li Xu; Chunguang Li; Yang Yuan; Shengdong Huang; Hezhong Chen
Journal:  Tumour Biol       Date:  2016-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.